1. Home
  2. PT vs ALLR Comparison

PT vs ALLR Comparison

Compare PT & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • ALLR
  • Stock Information
  • Founded
  • PT 2012
  • ALLR 2004
  • Country
  • PT China
  • ALLR United States
  • Employees
  • PT N/A
  • ALLR N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • ALLR Health Care
  • Exchange
  • PT Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • PT 15.2M
  • ALLR 15.8M
  • IPO Year
  • PT 2018
  • ALLR N/A
  • Fundamental
  • Price
  • PT $0.98
  • ALLR $0.90
  • Analyst Decision
  • PT
  • ALLR Strong Buy
  • Analyst Count
  • PT 0
  • ALLR 1
  • Target Price
  • PT N/A
  • ALLR $9.00
  • AVG Volume (30 Days)
  • PT 7.9K
  • ALLR 489.1K
  • Earning Date
  • PT 08-26-2025
  • ALLR 08-15-2025
  • Dividend Yield
  • PT N/A
  • ALLR N/A
  • EPS Growth
  • PT N/A
  • ALLR N/A
  • EPS
  • PT N/A
  • ALLR N/A
  • Revenue
  • PT $4,814,566.00
  • ALLR N/A
  • Revenue This Year
  • PT N/A
  • ALLR N/A
  • Revenue Next Year
  • PT N/A
  • ALLR N/A
  • P/E Ratio
  • PT N/A
  • ALLR N/A
  • Revenue Growth
  • PT N/A
  • ALLR N/A
  • 52 Week Low
  • PT $0.76
  • ALLR $0.61
  • 52 Week High
  • PT $1.15
  • ALLR $6.00
  • Technical
  • Relative Strength Index (RSI)
  • PT 53.96
  • ALLR 44.95
  • Support Level
  • PT $0.88
  • ALLR $0.93
  • Resistance Level
  • PT $0.98
  • ALLR $1.01
  • Average True Range (ATR)
  • PT 0.05
  • ALLR 0.05
  • MACD
  • PT 0.00
  • ALLR -0.01
  • Stochastic Oscillator
  • PT 59.58
  • ALLR 14.00

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: